Autocrine amplification loop in statin‐induced apoptosis of human melanoma cells
Authors:
Open Access
- 23 July 2009
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 157 (7) , 1278-1290
Abstract
Background and purpose: Beside their cholesterol lowering effect, statins exert pleiotropic effects, which include anti‐inflammatory, immunosuppressive and anti‐proliferative actions. In higher concentrations, statins trigger apoptosis in primary cells and tumour cells. In particular, melanoma cells have been found to be susceptible to statin‐induced apoptosis, although only after longer incubation times. The molecular mechanisms behind this delayed drug‐induced apoptosis are still unclear.Experimental approach: The human melanoma A375 and 518A2 cell lines were exposed to various statins in a time‐dependent and dose‐dependent manner, and indicators of apoptosis, caspase activity and individual apoptotic pathways were analysed for 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase dependent and independent effects.Key results: Kinetic analysis of statin‐induced apoptosis revealed an apoptotic burst for exposure times longer than 24 h. While the extrinsic pathway was not activated within 24 h, longer incubation times corroborated amplification of the mitochondrial pathway with significant activation of caspase 8. Continuous refreshing of the simvastatin‐containing medium abrogated the mitochondrial amplification loop via caspase 8. Moreover, conditional medium, supplemented with mevalonic acid in order to nullify a possible contamination by statins, significantly triggered caspase 8 activity. Fas ligand was excluded as a possible candidate to account for the statin‐induced autocrine amplification loop.Conclusions and implications: Simvastatin and atorvastatin are capable of triggering an ‘autocrine’ suicide factor, which amplifies apoptosis via the extrinsic pathway in human melanoma cells. This pro‐apoptotic stimulus implies possible therapeutic potential and may guide feasibility for more potent statins in anti‐cancer strategies.Keywords
This publication has 37 references indexed in Scilit:
- Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cellsMelanoma Research, 2008
- Statins and Cancer RiskThe American Journal of Medicine, 2008
- The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cellsBMC Cancer, 2008
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI: Journal of the National Cancer Institute, 2008
- Statins and cancer preventionNature Reviews Cancer, 2005
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Isoprenylation is Necessary for the Full Invasive Potential of RhoA Overexpression in Human Melanoma CellsJournal of Investigative Dermatology, 2002
- Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and LovastatinThe Journal of Clinical Pharmacology, 1990
- Regulation of the mevalonate pathwayNature, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976